Annual CFO
-$13.19 M
-$818.60 K-6.62%
December 31, 2023
Summary
- As of February 7, 2025, POAI annual cash flow from operations is -$13.19 million, with the most recent change of -$818.60 thousand (-6.62%) on December 31, 2023.
- During the last 3 years, POAI annual CFO has fallen by -$931.70 thousand (-7.60%).
- POAI annual CFO is now -1507.09% below its all-time high of -$820.70 thousand, reached on December 31, 2010.
Performance
POAI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.28 M
+$938.60 K+29.17%
September 30, 2024
Summary
- As of February 7, 2025, POAI quarterly cash flow from operations is -$2.28 million, with the most recent change of +$938.60 thousand (+29.17%) on September 30, 2024.
- Over the past year, POAI quarterly CFO has increased by +$938.60 thousand (+29.17%).
- POAI quarterly CFO is now -43736.54% below its all-time high of -$5200.00, reached on March 31, 2015.
Performance
POAI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$13.04 M
-$221.20 K-1.73%
September 30, 2024
Summary
- As of February 7, 2025, POAI TTM cash flow from operations is -$13.04 million, with the most recent change of -$221.20 thousand (-1.73%) on September 30, 2024.
- Over the past year, POAI TTM CFO has dropped by -$221.20 thousand (-1.73%).
- POAI TTM CFO is now -3775.99% below its all-time high of -$336.50 thousand, reached on March 31, 2009.
Performance
POAI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
POAI Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -6.6% | +29.2% | -1.7% |
3 y3 years | -7.6% | +36.2% | -0.8% |
5 y5 years | -149.4% | +36.2% | -0.8% |
POAI Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -8.0% | at low | -10.8% | +44.8% | -8.9% | +1.1% |
5 y | 5-year | -51.0% | at low | -10.8% | +44.8% | -49.4% | +1.1% |
alltime | all time | -1507.1% | at low | <-9999.0% | +48.5% | -3776.0% | +1.1% |
Predictive Oncology Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.28 M(-29.2%) | -$13.04 M(+1.7%) |
Jun 2024 | - | -$3.22 M(-5.8%) | -$12.82 M(-2.7%) |
Mar 2024 | - | -$3.42 M(-17.3%) | -$13.18 M(-0.1%) |
Dec 2023 | -$13.19 M(+6.6%) | -$4.13 M(+100.6%) | -$13.19 M(+7.3%) |
Sep 2023 | - | -$2.06 M(-42.4%) | -$12.30 M(-5.0%) |
Jun 2023 | - | -$3.57 M(+4.3%) | -$12.95 M(+1.9%) |
Mar 2023 | - | -$3.43 M(+6.0%) | -$12.70 M(+2.7%) |
Dec 2022 | -$12.37 M(+1.3%) | -$3.23 M(+19.5%) | -$12.37 M(-4.0%) |
Sep 2022 | - | -$2.71 M(-18.8%) | -$12.88 M(-1.8%) |
Jun 2022 | - | -$3.33 M(+7.8%) | -$13.11 M(+9.4%) |
Mar 2022 | - | -$3.09 M(-17.4%) | -$11.98 M(-1.9%) |
Dec 2021 | -$12.21 M(-0.4%) | -$3.74 M(+27.4%) | -$12.21 M(+13.4%) |
Sep 2021 | - | -$2.94 M(+33.2%) | -$10.77 M(-2.7%) |
Jun 2021 | - | -$2.20 M(-33.6%) | -$11.06 M(-12.2%) |
Mar 2021 | - | -$3.32 M(+44.2%) | -$12.61 M(+2.8%) |
Dec 2020 | -$12.26 M(+40.4%) | -$2.30 M(-28.7%) | -$12.26 M(-3.9%) |
Sep 2020 | - | -$3.23 M(-13.8%) | -$12.75 M(+11.8%) |
Jun 2020 | - | -$3.75 M(+26.1%) | -$11.41 M(+18.1%) |
Mar 2020 | - | -$2.97 M(+6.3%) | -$9.66 M(+10.6%) |
Dec 2019 | -$8.73 M(+65.1%) | -$2.80 M(+47.8%) | -$8.73 M(+22.0%) |
Sep 2019 | - | -$1.89 M(-5.3%) | -$7.16 M(+14.9%) |
Jun 2019 | - | -$2.00 M(-2.5%) | -$6.23 M(+10.3%) |
Mar 2019 | - | -$2.05 M(+68.2%) | -$5.64 M(+6.7%) |
Dec 2018 | -$5.29 M(+18.6%) | -$1.22 M(+26.6%) | -$5.29 M(-1.9%) |
Sep 2018 | - | -$962.20 K(-31.9%) | -$5.39 M(-1.9%) |
Jun 2018 | - | -$1.41 M(-16.6%) | -$5.50 M(+10.0%) |
Mar 2018 | - | -$1.69 M(+28.1%) | -$5.00 M(+12.1%) |
Dec 2017 | -$4.46 M(+1.8%) | -$1.32 M(+24.0%) | -$4.46 M(+16.9%) |
Sep 2017 | - | -$1.07 M(+16.6%) | -$3.81 M(+4.0%) |
Jun 2017 | - | -$914.60 K(-20.9%) | -$3.67 M(-7.1%) |
Mar 2017 | - | -$1.16 M(+70.8%) | -$3.95 M(-9.9%) |
Dec 2016 | -$4.38 M | -$677.10 K(-26.4%) | -$4.38 M(-33.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | -$919.70 K(-23.1%) | -$6.55 M(-34.8%) |
Jun 2016 | - | -$1.20 M(-24.6%) | -$10.06 M(+10.9%) |
Mar 2016 | - | -$1.59 M(-44.3%) | -$9.07 M(+21.1%) |
Dec 2015 | -$7.49 M(+122.1%) | -$2.85 M(-35.6%) | -$7.49 M(+53.9%) |
Sep 2015 | - | -$4.42 M(+2012.1%) | -$4.87 M(+197.0%) |
Jun 2015 | - | -$209.40 K(+3926.9%) | -$1.64 M(+0.9%) |
Mar 2015 | - | -$5200.00(-97.7%) | -$1.62 M(-51.8%) |
Dec 2014 | -$3.37 M(-12.5%) | -$228.70 K(-80.9%) | -$3.37 M(-7.9%) |
Sep 2014 | - | -$1.20 M(+512.9%) | -$3.66 M(-0.5%) |
Jun 2014 | - | -$195.00 K(-88.9%) | -$3.68 M(-21.2%) |
Mar 2014 | - | -$1.75 M(+237.6%) | -$4.67 M(+21.1%) |
Dec 2013 | -$3.86 M(+225.6%) | -$519.00 K(-57.2%) | -$3.86 M(+3.1%) |
Sep 2013 | - | -$1.21 M(+2.6%) | -$3.74 M(+40.4%) |
Jun 2013 | - | -$1.18 M(+25.8%) | -$2.66 M(+42.1%) |
Mar 2013 | - | -$940.30 K(+133.0%) | -$1.87 M(+58.3%) |
Dec 2012 | -$1.18 M(-33.5%) | -$403.50 K(+195.4%) | -$1.18 M(-14.0%) |
Sep 2012 | - | -$136.60 K(-65.3%) | -$1.38 M(-14.9%) |
Jun 2012 | - | -$393.90 K(+57.4%) | -$1.62 M(-2.8%) |
Mar 2012 | - | -$250.20 K(-58.0%) | -$1.66 M(-6.6%) |
Dec 2011 | -$1.78 M(+117.1%) | -$595.70 K(+57.6%) | -$1.78 M(+44.4%) |
Sep 2011 | - | -$378.10 K(-14.1%) | -$1.23 M(+13.2%) |
Jun 2011 | - | -$440.40 K(+19.9%) | -$1.09 M(+22.1%) |
Mar 2011 | - | -$367.40 K(+671.8%) | -$892.80 K(+8.8%) |
Dec 2010 | -$820.70 K(-37.4%) | -$47.60 K(-79.7%) | -$820.70 K(-25.2%) |
Sep 2010 | - | -$234.60 K(-3.5%) | -$1.10 M(-3.9%) |
Jun 2010 | - | -$243.20 K(-17.6%) | -$1.14 M(-10.0%) |
Mar 2010 | - | -$295.30 K(-9.0%) | -$1.27 M(-3.1%) |
Dec 2009 | -$1.31 M(+45.5%) | -$324.50 K(+16.5%) | -$1.31 M(+32.9%) |
Sep 2009 | - | -$278.60 K(-24.8%) | -$985.50 K(+39.4%) |
Jun 2009 | - | -$370.40 K(+10.1%) | -$706.90 K(+110.1%) |
Mar 2009 | - | -$336.50 K | -$336.50 K |
Dec 2008 | -$900.50 K | - | - |
FAQ
- What is Predictive Oncology annual cash flow from operations?
- What is the all time high annual CFO for Predictive Oncology?
- What is Predictive Oncology annual CFO year-on-year change?
- What is Predictive Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Predictive Oncology?
- What is Predictive Oncology quarterly CFO year-on-year change?
- What is Predictive Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Predictive Oncology?
- What is Predictive Oncology TTM CFO year-on-year change?
What is Predictive Oncology annual cash flow from operations?
The current annual CFO of POAI is -$13.19 M
What is the all time high annual CFO for Predictive Oncology?
Predictive Oncology all-time high annual cash flow from operations is -$820.70 K
What is Predictive Oncology annual CFO year-on-year change?
Over the past year, POAI annual cash flow from operations has changed by -$818.60 K (-6.62%)
What is Predictive Oncology quarterly cash flow from operations?
The current quarterly CFO of POAI is -$2.28 M
What is the all time high quarterly CFO for Predictive Oncology?
Predictive Oncology all-time high quarterly cash flow from operations is -$5200.00
What is Predictive Oncology quarterly CFO year-on-year change?
Over the past year, POAI quarterly cash flow from operations has changed by +$938.60 K (+29.17%)
What is Predictive Oncology TTM cash flow from operations?
The current TTM CFO of POAI is -$13.04 M
What is the all time high TTM CFO for Predictive Oncology?
Predictive Oncology all-time high TTM cash flow from operations is -$336.50 K
What is Predictive Oncology TTM CFO year-on-year change?
Over the past year, POAI TTM cash flow from operations has changed by -$221.20 K (-1.73%)